News
Ozempic, the blockbuster diabetes treatment from Novo Nordisk, could be next in line to face price negotiations between manufacturers and Medicare. The Biden administration released the first 10 ...
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
1d
News Nation on MSNGLP-1 drugs like Ozempic have ‘surprising’ positive effects: DoctorA study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic, were linked to a 33% lower risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results